GlassScriptPhysician profile
George Lee Franklin
NPI 1417967951
$760.47
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $188 · 2021: $343.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $306.73 | 2019-2021 | |
| Emd Serono, INC. | $248.65 | 2019-2021 | |
| Viiv Healthcare Company | $81.07 | 2020-2021 | |
| Janssen Biotech, INC. | $44.30 | 2020-2021 | |
| Lilly USA, LLC | $27.39 | 2019-2020 | |
| Abbvie INC. | $20.62 | 2019 | |
| Hologic Sales and Service, LLC | $16.92 | 2021 | |
| Merck Sharp & Dohme LLC | $14.79 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.